Rachman Ilya M
SEC insider (Form 3/4/5 filer). CIK 0001889334. CEO and Chairman at Immix Biopharma, Inc. (IMMX). 5 reported Form 4/5 transactions since Sep 2024; latest on May 22, 2026. Located in LOS ANGELES, CA.
Companies Rachman Ilya M has filed insider reports for
- Immix Biopharma, Inc. (IMMX): Director, Officer, CEO and Chairman
Rachman Ilya M
CIK: 0001889334
Transaction Breakdown
Open Market Buys (P)3 (60.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMMX
Immix Biopharma, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 22, 2026IMMX
Immix Biopharma, Inc.
AwardDirectStock Option (Right to Buy)
500K shares- - Dec 10, 2025IMMX
Immix Biopharma, Inc.
PurchaseDirect746 shares at avg. $6.67$5K - Sep 17, 2025IMMX
Immix Biopharma, Inc.
PurchaseDirect2.5K shares at avg. $2.02$5K - Jun 20, 2025IMMX
Immix Biopharma, Inc.
AwardDirectStock Option (Right to Buy)
340K shares- - Jun 18, 2025IMMX
Immix Biopharma, Inc.
PurchaseDirect2.2K shares at avg. $2.29$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 22, 2026 | IMMX Immix Biopharma, Inc. | Award Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| Dec 10, 2025 | IMMX Immix Biopharma, Inc. | Purchase | 746 | $6.67 | $4,976 | Direct |
| Sep 17, 2025 | IMMX Immix Biopharma, Inc. | Purchase | 2,500 | $2.02 | $5,050 | Direct |
| Jun 20, 2025 | IMMX Immix Biopharma, Inc. | Award Stock Option (Right to Buy) | 340,000 | - | - | Direct |
| Jun 18, 2025 | IMMX Immix Biopharma, Inc. | Purchase | 2,178 | $2.29 | $4,999 | Direct |
1-5 of 5 transactions